Profile | GDS4284 / 243835_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1569.5 | 80 |
GSM687648 | Patient 402 control | 854.717 | 72 |
GSM687653 | Patient 403 control | 1668.54 | 82 |
GSM687658 | Patient 404 control | 854.371 | 72 |
GSM687663 | Patient 411 control | 1466.86 | 80 |
GSM687668 | Patient 422 control | 1352.02 | 78 |
GSM687673 | Patient 424 control | 1402.96 | 79 |
GSM687678 | Patient 425 control | 652.955 | 67 |
GSM687683 | Patient 427 control | 1334.33 | 78 |
GSM687688 | Patient 428 control | 1833.27 | 83 |
GSM687695 | Patient 441 control | 249.165 | 44 |
GSM687699 | Patient 443 control | 1575.27 | 81 |
GSM687704 | Patient 444 control | 964.012 | 73 |
GSM687707 | Patient 448 control | 1267.15 | 78 |
GSM687712 | Patient 449 control | 1415.45 | 79 |
GSM687719 | Patient 450 control | 751.783 | 69 |
GSM687724 | Patient 451 control | 1743.51 | 82 |
GSM687728 | Patient 452 control | 1503.48 | 80 |
GSM687646 | Patient 401 treated 24h | 1895.94 | 83 |
GSM687649 | Patient 402 treated 24h | 1565.26 | 80 |
GSM687665 | Patient 411 treated 24h | 1383.05 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 960.421 | 73 |
GSM687667 | Patient 411 treated 4 weeks | 1814.37 | 82 |
GSM687670 | Patient 422 treated 24h | 1684.46 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1560.59 | 80 |
GSM687654 | Patient 403 treated 24h | 1872.75 | 83 |
GSM687675 | Patient 424 treated 24h | 1130.19 | 76 |
GSM687685 | Patient 427 treated 24h | 1431.62 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1869.55 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 1519.2 | 80 |
GSM687687 | Patient 427 treated 4 weeks | 1611.28 | 81 |
GSM687692 | Patient 428 treated 4h | 1299.37 | 78 |
GSM687716 | Patient 449 treated 4h | 1171.64 | 77 |
GSM687722 | Patient 450 treated 4h | 663.386 | 67 |
GSM687680 | Patient 425 treated 24h | 687.195 | 68 |
GSM687690 | Patient 428 treated 24h | 1841.45 | 83 |
GSM687700 | Patient 443 treated 24h | 933.118 | 72 |
GSM687705 | Patient 444 treated 24h | 1370.2 | 79 |
GSM687714 | Patient 449 treated 24h | 1220.37 | 77 |
GSM687721 | Patient 450 treated 24h | 463.292 | 61 |
GSM687682 | Patient 425 treated 4 weeks | 972.647 | 74 |
GSM687694 | Patient 428 treated 4 weeks | 1105.12 | 75 |
GSM687702 | Patient 443 treated 4 weeks | 1483.35 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1261.05 | 78 |
GSM687723 | Patient 450 treated 4 weeks | 839.651 | 71 |
GSM687661 | Patient 404 treated 4h | 892.559 | 72 |
GSM687710 | Patient 448 treated 4h | 1081.73 | 76 |
GSM687726 | Patient 451 treated 4h | 1648.84 | 81 |
GSM687730 | Patient 452 treated 4h | 846.512 | 70 |
GSM687660 | Patient 404 treated 24h | 299.447 | 53 |
GSM687697 | Patient 441 treated 24h | 808.345 | 71 |
GSM687709 | Patient 448 treated 24h | 1536.18 | 81 |
GSM687725 | Patient 451 treated 24h | 1373.47 | 79 |
GSM687729 | Patient 452 treated 24h | 401.693 | 59 |
GSM687727 | Patient 451 treated 4 weeks | 2112.95 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 973.416 | 73 |